BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15772347)

  • 1. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.
    Köfalvi A; Rodrigues RJ; Ledent C; Mackie K; Vizi ES; Cunha RA; Sperlágh B
    J Neurosci; 2005 Mar; 25(11):2874-84. PubMed ID: 15772347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens.
    Sperlágh B; Windisch K; Andó RD; Sylvester Vizi E
    Neurochem Int; 2009 Jun; 54(7):452-7. PubMed ID: 19428788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action.
    Köfalvi A; Vizi ES; Ledent C; Sperlágh B
    Eur J Neurosci; 2003 Oct; 18(7):1973-8. PubMed ID: 14622229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus.
    Balázsa T; Bíró J; Gullai N; Ledent C; Sperlágh B
    Neurochem Int; 2008 Jan; 52(1-2):95-102. PubMed ID: 17719142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices.
    Mendiguren A; Pineda J
    Br J Pharmacol; 2009 Nov; 158(6):1579-87. PubMed ID: 19845674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
    Gerdeman G; Lovinger DM
    J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.
    Kawamura Y; Fukaya M; Maejima T; Yoshida T; Miura E; Watanabe M; Ohno-Shosaku T; Kano M
    J Neurosci; 2006 Mar; 26(11):2991-3001. PubMed ID: 16540577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid 1 and transient receptor potential vanilloid 1 receptors discretely modulate evoked glutamate separately from spontaneous glutamate transmission.
    Fawley JA; Hofmann ME; Andresen MC
    J Neurosci; 2014 Jun; 34(24):8324-32. PubMed ID: 24920635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.
    Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ
    Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
    Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
    Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
    Liu Q; Bhat M; Bowen WD; Cheng J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
    Hájos N; Ledent C; Freund TF
    Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC
    Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta.
    Schultheiss T; Flau K; Kathmann M; Göthert M; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):139-46. PubMed ID: 16195872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
    McMahon LR; Koek W
    Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease.
    Chiodi V; Uchigashima M; Beggiato S; Ferrante A; Armida M; Martire A; Potenza RL; Ferraro L; Tanganelli S; Watanabe M; Domenici MR; Popoli P
    Neurobiol Dis; 2012 Mar; 45(3):983-91. PubMed ID: 22207189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the effects of cannabinoids on synaptic transmission between basket and Purkinje cells in the cerebellar cortex of the rat.
    Szabo B; Than M; Thorn D; Wallmichrath I
    J Pharmacol Exp Ther; 2004 Sep; 310(3):915-25. PubMed ID: 15123767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
    Lee SH; Ledri M; Tóth B; Marchionni I; Henstridge CM; Dudok B; Kenesei K; Barna L; Szabó SI; Renkecz T; Oberoi M; Watanabe M; Limoli CL; Horvai G; Soltesz I; Katona I
    J Neurosci; 2015 Jul; 35(27):10039-57. PubMed ID: 26157003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptor agonists inhibit Ca(2+) influx to synaptosomes from rat brain.
    Yoshihara S; Morimoto H; Ohori M; Yamada Y; Abe T; Arisaka O
    Pharmacology; 2006; 76(4):157-62. PubMed ID: 16446560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.